M. Arendrup

Clinical Microbiology and Infection · 2008–2019

A researcher in the Science corpus: 7 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Who trusts M. Arendrup overall

  1. M. Pfaller

Papers from M. Arendrup's perspective

Ordered by how strongly the researchers M. Arendrup trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial. (The Lancet)
  2. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. (New England Journal of Medicine)
  3. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. (Clinical Infectious Diseases)
  4. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. (Clinical Infectious Diseases)
  5. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. (New England Journal of Medicine)
  6. Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial. (Clinical Infectious Diseases)
  7. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. (Clinical Infectious Diseases)
  8. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management (European Respiratory Journal)
  9. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. (Clinical Infectious Diseases)
  10. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. (Clinical Infectious Diseases)

Their papers